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EFFECTS OF TOBACCO ON HUMAN GINGIVAL FIBROBLASTS 
 
The negative heath consequences of smoking are widely recognized, but there are still 
about 20% of the people in United States using tobacco products.  Cigarette smoke 
condensate (CSC), the particulate matter of cigarette smoke, is comprised of thousands of 
chemicals (e.g., nicotine).  Secondary only to bacterial plaque, cigarette smoking is a 
major risk factor for periodontal disease.  Human gingival fibroblasts (HGFs) are the 
main cellular component of periodontal connective tissues.  During the development of 
periodontal disease, collagen degradation occurs.  Collagen is the major extracellular 
matrix component of the gingiva.  The major extracellular matrix degrading enzymes 
produced by the HGFs are the matrix metalloproteinases (MMPs). The MMPs are mainly 
modulated by the tissue inhibitors of metalloproteinases (TIMPs).  In this dissertation, 
three studies aimed at understanding the effects of tobacco on human gingival fibroblasts 
and their mechanisms have been conducted: the effects of CSC on HGF-mediated 
collagen degradation; comparison of the effects of CSC on HGFs with that of nicotine; 
and the combined effects of CSC and bacteria on HGFs.   
 
The cell proliferation of HGFs decreased and cytotoxicity increased in HGFs treated with 
increasing concentrations of CSC.  CSC increased the collagen degrading ability of the 
HGFs by altering the production and localization of MMPs and TIMPs.  
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Nicotine is one of the major components and the most pharmacologically active agent in 
tobacco.  The percentage of nicotine in the CSC was 2.4%.  CSC (100 µg/ml) increased 
the collagen degrading ability of the HGFs by affecting membrane associated MMP-2, 
MMP-14, and TIMP-2, but the level of nicotine in the CSC may only play a limited role 
in this process. 
 
Porphyromonas gingivalis (P. gingivalis) is an opportunistic pathogen involved in 
periodontal disease.  The combined effects of CSC and P. gingivalis supernatant 
increased HGF-mediated collagen degradation by destroying the balance between the 
MMPs and TIMPs at the protein and mRNA levels.  
 
This project demonstrated that tobacco (with or without P. gingivalis) increased HGF 
mediated collagen degradation, as seen in the periodontal disease, through altering the 
MMPs and TIMPs. 
 
L. Jack Windsor, Ph.D., Chair 
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Smoking is one of the main etiologies of human death every year.  It is responsible for 
multiple cancers, cardiovascular diseases, respiratory diseases, and many other harmful 
health conditions.  Furthermore, cigarette smoking is a risk factor for oral cancer, oral 
mucosal lesions, and periodontal disease.   
 
Periodontal disease is a chronic infectious disease of the supportive tissues of teeth.  It is 
the main cause of tooth loss among adults.  Periodontal disease is very common and 
affects about 90% of the worldwide population (Pihlstrom et al., 2005).  Just behind 
bacterial plaque, cigarette smoking is ranked second as a major risk factor for periodontal 
disease (Fang and Svoboda, 2005; Ryder, 2007) and even promotes its development 
(Barbour et al., 1997; Hilgers and Kinane, 2004; Pihlstrom et al., 2005; Rivera-Hidalgo, 
2003).  It is evident that smoking patients have greater bone loss, greater attachment loss, 
and deeper periodontal pockets than non-smoking patients (Bergstrom, 2004).  
Furthermore, the outcome of the treatment of periodontal disease is also less favorable in 
smoking patients (Bergstrom, 2004).  In the USA, smoking contributes to about half of 
the risk of developing periodontal disease (Hujoel et al., 2003; Tomar and Asma, 2000).  
 
During the development of periodontal disease, collagen degradation occurs.  Collagen is 
the major extracellular matrix component of the gingiva.  The major extracellular matrix 
degrading enzymes, produced by the human gingival fibroblasts (HGFs), are the matrix 
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metalloproteinases (MMPs).  The MMPs play important roles in both physiological and 
pathological conditions.  Several members of the MMP family have been shown to be 
involved in periodontal tissue destruction (Hannas et al., 2007; Sorsa et al., 2004).  The 
MMPs, which are secreted by various cell types and found in most body fluids and 
tissues, are mainly modulated by the tissue inhibitors of metalloproteinases (TIMPs).  
The balance in the activities of the MMPs/TIMPs is considered to be important to 
periodontal health and tobacco may affect this balance (Verstappen and Von den Hoff, 
2006).   
 
Cigarette smoking condensate (CSC) is the particulate matter of cigarette smoke and 
contains thousands of chemicals (Gao et al., 2005b). Nicotine is one of the 
pharmacologically active agents in CSC.  It has been used to study the effects of smoking 
on periodontal tissue.  Nicotine can increase HGF-mediated collagen degradation at 250 
µg/ml, partly through the activation of membrane-associated MMPs (Zhou et al., 2007).  
Nicotine (250 µg/ml), Porphyromonas gingivalis (P. gingivalis) lipopolysaccharide 
(LPS), or a combination of both agents can increase the production of multiple cytokines 
and growth factors in HGFs (Almasri et al., 2007).  Other previous studies demonstrated 
that nicotine affects gingival blood flow (Johnson et al., 1991; Morozumi et al., 2004), 
cytokine production (Wendell and Stein, 2001), and connective tissue cells such as 
fibroblasts in aspects of cell morphology, attachment to substrates, and protein synthesis 
and secretion (Chamson et al., 1982; Peacock et al., 1993).  However, nicotine is just one 
of the thousands of chemicals in CSC.  Currently, there is little data on the effects of CSC 
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The overall goal of this study was to examine the CSC stimulated collagen-degrading 
ability of HGFs. The study was accomplished by the following three specific aims. 
 
Specific Aim 1: To assess the effects of CSC on the collagen-degrading ability of HGFs. 
 
Periodontal disease has been recognized to be a host-mediated inflammatory disease.  
The host responses to periodontal infection plays a major role in the pathogenesis of 
periodontal disease (Pihlstrom et al., 2005).  The health of periodontal tissues depends on 
the normal functions of periodontal cells.  The attachment, migration, growth, and 
differentiation of periodontal cells are critical steps in the repair and regeneration of 
periodontal tissues.  Human gingival fibroblasts (HGFs) are the main cellular component 
of periodontal connective tissues.  Therefore, the normal functions of HGFs are very 
important to periodontal health.   
 
During the development of periodontal disease, collagen degradation occurs.  Collagen is 
the major extracellular matrix component of the gingiva.  The major extracellular matrix 
degrading enzymes produced by the HGFs are the matrix metalloproteinases (MMPs).  
These enzymes are a group of zinc-dependent endopeptidases that include the 
collagenases, gelatinases, stromelysins, and membrane-associated MMPs.  Several 
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members of the MMP family have been shown to be involved in periodontal tissue 
destruction and these include MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-13, and 
MMP-14 (Hannas et al., 2007; Sorsa et al., 2004).  The MMPs are mainly modulated by 
the tissue inhibitors of metalloproteinases (TIMPs), which are secreted by various cell 
types and found in most body fluids and tissues.   
 
Cigarette smoking is a risk factor for periodontal disease and cigarette smoking 
condensate (CSC) is the particulate matter of cigarette smoke.  Currently, there is little 
data on the effects of CSC on HGFs.  Thus, the goal of this specific aim was to examine 
the effects of CSC on the collagen-degrading ability of HGFs, as well as on the 
production of multiple MMPs and TIMPs. 
 
Specific Aim 2: To compare the effects of CSC and nicotine on HGF mediated collagen-
degradation and examine their mechanisms. 
 
CSC is comprised of thousands of chemicals, which are powerful inducers of 
inflammatory responses (Gao et al., 2005b).  CSC may destroy the balance of the 
MMPs/TIMPs and alter the localization of MMPs and TIMPs (especially membrane 
associated MMP-2, MMP-14, and TIMP-2) to promote the degradation of extracellular 
matrix (ECM), which occurs in periodontal disease (Zhang et al., 2009).  Nicotine is one 
pharmacologically active agent in CSC.  Many previous studies demonstrated that 
nicotine may play important roles in the development of periodontal disease (Almasri et 
al., 2007; Chamson et al., 1982; Johnson et al., 1991; Morozumi et al., 2004; Peacock et 
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al., 1993; Wendell and Stein, 2001; Zhou et al., 2007).  However, there is no data that 
compares the effects of nicotine and CSC on HGFs.  The goal of this specific aim was to 
compare the effects of CSC with nicotine on the collagen degrading ability of HGFs and 
the expression of selected MMPs and tissue inhibitors of metalloproteinases (TIMPs). 
 
Specific Aim 3: To assess the combined effects of CSC and Porphyromonas  gingivalis 
on the collagen degrading ability of HGFs. 
 
Porphyromonas gingivalis (P. gingivalis) has been implicated as a major etiologic agent 
in the development and progress of periodontal disease (Andrian et al., 2006).  P. 
gingivalis can disrupt MMP-9 production (Andrian et al., 2006; DeCarlo et al., 1998; 
DeCarlo et al., 1997) and elevate MMP-2 production in periodontal ligament cell cultures 
(Chang et al., 2002b).  Purified gingipains, trypsin-like proteinases from P. gingivalis, 
can up-regulate MMP-8 and MMP-3 expression in rat mucosal epithelial cells (DeCarlo 
et al., 1998) and activate latent MMPs (DeCarlo et al., 1997; Grayson et al., 2003).  
Furthermore, P. gingivalis can up-regulate the collagen degrading ability of some human 
gingival fibroblast (HGF) cell lines, in part, by increasing MMP activation and by 
lowering the TIMP-1 protein level, as well as by affecting the mRNA expression of 
multiple MMPs and TIMPs (Zhou and Windsor, 2006). 
 
Numerous studies have evaluated the effects of either P. gingivalis and/or nicotine on 
HGF function (Almasri et al., 2007; Bosco et al., 2007; Makino et al., 2008; Mineoka et 
al., 2008; Noiri et al., 2004).  However, nicotine is just one of the active components in 
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CSC and no data about the combined effects of CSC and P. gingivalis on HGFs has been 
reported.  Given the strong association between periodontal disease and P. gingivalis, as 
well as between periodontal disease and smoking, the goal of this specific aim was to 
investigate the combined effects of CSC and P. gingivalis on the collagen degrading 
ability of HGFs, as well as their effects on multiple MMPs and TIMPs at the protein and 
mRNA levels. 
 
Background and Significance 
Cigarette Smoking  
The negative health consequences of smoking are widely recognized.  However, still 
about 20% of the people in the United States use tobacco (Office-of-Applied-Studies, 
2005).  Smoking harms virtually every organ in the body.  United States Surgeon 
General’s Report linked cigarette smoking to lung cancer and cardiovascular disease 
more than 40 years ago (Guthrie, 1966).  Since then, the list of smoking-related health 
effects has grown and cigarette smoking is recognized as the major preventable cause of 
death in the United States.  Smoking individuals are generally less healthy with impaired 
immune systems and increased risk of infections.  Studies have shown that smoking is 
associated with diabetes, skin diseases, and gastrointestinal diseases (Johnson and 
Guthmiller, 2007; Winn, 2001).  Furthermore, passive smoking or involuntary exposure 
to tobacco smoke may result in severe health consequences (Johnson and Guthmiller, 
2007; Winn, 2001). 
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CSC is a complex mixture that contains more than 6,000 chemicals (e.g., nicotine, 
cadmium, phenol, anthracyclic hydrocarbons, nitrosamines, heavy metals and chemical 
carcinogens) (Gao et al., 2005b).  Based on the CSC manufacturer’s information (Murty 
Pharmaceuticals, Lexington, KY), CSC is usually prepared by using a Phippps-Bird 20-
channel smoking machine designed for Federal Trade Commission (FTC) testing.  The 
smoke particulates are collected on Cambridge glass fiber filters from the University of 
Kentucky’s standard cigarettes (1R3F: University of Kentucky, KY) and dissolved in 
dimethylsulphoxide (DMSO) at 40 mg/ml.  Every cigarette produces 26.1 mg of CSC 
(Murty Pharmaceuticals, Lexington, KY) with 2.4% nicotine.  
 
Periodontal Disease 
Widely defined periodontal disease includes any inherited or acquired disorder of the 
periodontium.  It may origin from development, inflammation, trauma, neoplasm, genetic 
disease, or metabolic disorders (Pihlstrom et al., 2005).  However, the term periodontal 
disease usually refers to the common inflammatory disorders of gingivalis and 
periodontitis, which are caused by pathologenic microflora in the biofilm or dental plaque.  
These dental plaques form adjacent to the teeth on a daily basis (Pihlstrom et al., 2005).  
Gingivitis is the mildest form of periodontal disease.  It is caused by bacterial biofilm, 
which accumulates on teeth adjacent to the gingiva (gums). Gingivitis does not affect the 
underlying teeth supporting structures and is reversible. Untreated gingivitis may develop 
into periodontitis.  Periodontal disease results in loss of bone supporting tissues and 
connective tissues.  Periodontitis is a major cause of tooth loss in adults.  Periodontal 
disease is highly prevalent and can affect up to 90% of the worldwide population 
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(Pihlstrom et al., 2005).  In addition to pathologenic bacteria in the dental plaque, genetic 
and environmental factors, especially tobacco use, contribute to periodontal disease.   
 
Although bacteria are necessary for periodontal disease to occur, a susceptible host is also 
needed.  The immune-inflammatory responses develop in the periodontal tissues in 
response to the chronic presence of bacteria plaque.  These responses result in destruction 
of structural components of the periodontium, which leads, ultimately, to the clinical 
signs of periodontal disease (Pihlstrom et al., 2005).  
 
Both the host and bacteria in periodontal biofilm can release proteolytic enzymes.  These 
enzymes can damage tissue. Chemotactic factors, which recruit polymorphonuclear 
leucocytes (PMNs) into the tissues, can also be released; if sustained, various enzymes 
that break down tissues can be released by the PMNs (Pihlstrom et al., 2005).  These 
enzymes include the MMPs, cathepsins and other proteinases (Ryder, 2007).  
 
Tobacco use is one of the most significant risk factors for the development of periodontal 
disease.  Smokers are much more likely to development periodontitis than non-smokers 
(Bergstrom, 2004).  Oral smokeless tobacco can also result in gingivitis and loss of tooth 
support tissue (Robertson et al., 1990).  Furthermore, smoking has strong negative effects 
in response to periodontal treatment and other oral surgical interventions (Bergstrom, 
2004).  The proposed mechanisms for the negative periodontal effects of smoking may 
include but not restrict to: decreasing immunoglobulin G2 production; shifting in 
neutrophil functions towards destructive activities (e.g., superoxide and hydrogen 
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peroxide generation); causing negative effects on cytokine and growth factor production 
(e.g., interleukin-1beta, interleukin-8, and tumor necrosis factor-alpha); and even 
inhibiting fibroblast growth, attachment and collagen production (Johnson and 
Guthmiller, 2007) 
 
The health of periodontal tissues depends on the normal functions of periodontal cells.  
The attachment, migration, growth, and differentiation of periodontal ligament cells are 
critical steps in the repair and regeneration of periodontal tissues (Ryder, 2007).  Human 
gingival fibroblasts are the main cellular component of periodontal connective tissues.  
Therefore, they are crucial in maintaining the connective tissues which support and 
anchor the teeth (Phipps et al., 1997).   
 
Matrix Metalloproteinases (MMPs) 
MMPs are a large family of zinc-dependent endopeptidases, which are capable of 
digesting the ECM.  They include the collagenases, gelatinases, stromelysins, membrane-
associated MMPs, and others (Table 1.1) (Birkedal-Hansen et al., 1993; Chaussain-Miller 
et al., 2006; Sorsa et al., 2004).  At least 25 members of the MMP family have been 
discovered to date.   
 
The MMPs are responsible for a wide range of proteolytic events.  They play important 
roles in both physiological conditions (e.g., wound healing and tooth formation) and 
pathological conditions (e.g., inflammatory diseases and tumor invasion) (Sorsa et al., 
2004).  MMPs have also been shown to be involved in the functional regulation of host 
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non-ECM molecules, which include growth factors and their receptors, cytokines and 
chemokines, adhesion receptors and cell surface proteoglycans, and a variety of enzymes.  
As for all secreted proteinases, the catalytic activity of the MMPs is regulated at multiple 
points: (1) gene expression, (2) compartmentalization (i.e., pericellular accumulation of 
enzyme), (3) proenzyme (or zymogen) activation, and (4) enzyme inactivation, as well as  
(5) substrate availability and affinity (Ra and Parks, 2007).  Most of the MMPs appear to 
be secreted as proenzymes.  By cleaving the propeptides of the proMMPs, proMMPs can 
be activated to perform proteolysis.  Some MMPs can activate other members of the 
MMP family.  For example, MMP-14 can activate MMP-2 directly or indirectly by 
forming MMP-2-TIMP-2-MMP-14 complexes; MMP-2 and MMP-3 can active MMP-9; 
and MMP-3 can active MMP-1 (Sorsa et al., 2004). 
 
TIMPs, which are secreted by multiple cell types and are found in most body fluids and 
tissues, are important endogenous MMP inhibitors.  So far, four TIMPs (TIMP-1, -2, -3 
and -4) have been identified (Sorsa et al., 2004).  Usually, TIMPs bind to MMPs at a ratio 
of 1:1.  The TIMPs fit into the active-site cleft of MMPs in a manner similar to that of the 
substrate.  By forming complexes with MMPs, they may block activation of latent pro-
MMPs or influence their ability to hydrolyze a particular substrate.  The TIMP-2 
molecule serves as a bridging molecule for the binding of latent pro-MMP-2 to active 
MMP-14 on the cell membrane.  Another active MMP-14 in the cell membrane cleaves 
the propeptide domain of proMMP-2 in this trimolecular complex, which activates pro-
MMP-2.  Therefore, more TIMP-2 could be recruited to the cell membrane to enhance 
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MMP-2 activation (Strongin et al., 1995). The balance of the MMPs/TIMPs is important 
to health (Verstappen and Von den Hoff, 2006). 
 
The MMPs play major roles in the development of periodontal disease.  Several members 
of the MMP family (e.g., MMP-1, MMP-2, MMP-3, MMP-8, MMP-9, MMP-13, and 
MMP-14) have been shown to be involved in periodontal tissue destruction (Sorsa et al., 
2004).  For instance, MMP-2 and MMP-9 participated in the tissue destruction seen in 
periodontitis (Hannas et al., 2007).  The amount of the gelatinases (MMP-2 and MMP-9) 
increased during periodontal disease, while conventional periodontal treatment 
effectively reduced the levels of these enzymes (Makela et al., 1994).  Furthermore,  
increased MMP-14 (membrane-type I MMP) occurred in the subepithelial fibroblasts in 
inflamed gingiva (Tervahartiala et al., 2000).  MMP-14,  by activating pro-MMP-2, -8, 
and -13, is responsible for collagenous and non-collagenous extracellular matrix 
destruction (Wahlgren et al., 2001).  The subantimicrobial-dose doxycycline (SDD), a 
MMP inhibitor, along with the traditional mechanical therapies, has been widely used as 
an adjunctive systemic therapy in the management of periodontal disease (Giannobile, 
2008).  
 
CSC can also affect the production of MMPs.  Exposure of endothelial cells to CSC 
resulted in the upregulation of MMP-1, MMP-8, and MMP-9 mRNA expression 
(Nordskog et al., 2005).  Nicotine can bind to the root surfaces of teeth, and alter gingival 
and periodontal ligament fibroblast attachment and proliferation in vivo (Chang et al., 
2002a; Gamal and Bayomy, 2002; Giannopoulou et al., 1999; James et al., 1999).  
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Nicotine itself may increase the destruction of the gingival ECM during smokeless 
tobacco use (Tipton and Dabbous, 1995).  In an animal model, after cutaneous tissue 
exposure to cigarette smoke, an increase of basal MMP-2 (pro- and active form) occurs; 
however, TIMP-1 and 2 expression levels did not change, which could result in a net 
increase in matrix degradation  (Fortino et al., 2007). 
 
Porphyromonas gingivalis 
P. gingivalis is a gram-negative black-pigmented strict anaerobic bacterium (Andrian et 
al., 2006).  P. gingivalis produces a broad array of potential virulence factors, which are 
involved in tissue colonization and destruction, as well as in host defense perturbation.  
P. gingivalis has been implicated as a major etiologic agent in the development and 
progress of periodontitis.  It is frequently isolated from periodontal pockets of 
periodontitis patients and it can produce multiple proteinases (Kinane et al., 2008).   
 
P. gingivalis has been reported to affect the release and activation of certain MMPs from 
periodontal fibroblasts.  P. gingivalis can disrupt MMP-9 production by gingival 
epithelial cells and interfere with ECM repair and re-organization (Andrian et al., 2006; 
DeCarlo et al., 1998; DeCarlo et al., 1997).  Purified gingipains,  which are trypsin-like 
proteinases and components of the P. gingivalis supernatant,  can up-regulate MMP-8 
and MMP-3 expression in rat mucosal epithelial cells (DeCarlo et al., 1998) and activate 
latent  MMPs such as proMMP-1, -3, and -9 (DeCarlo et al., 1997).  P. gingivalis Arg-
gingipain in gingival cervical fluid (GCF) can also activate proMMP-2 (Grayson et al., 
2003).  Moreover, P. gingivalis has been shown to elevate MMP-2 production in 
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periodontal ligament cell cultures in a dose- and time-dependent manner (Chang et al., 
2002b).  Furthermore, partly by increasing MMP activation and by lowering the TIMP-1 
protein levels, as well as by affecting the mRNA expression of multiple MMPs and 
TIMPs, P. gingivalis supernatant can up-regulate the collagen-degrading ability of some 
HGF cell lines (Zhou and Windsor, 2006).  
 
Dissertation Outline 
This dissertation is divided into five chapters. Chapter one (the current chapter) is a 
general introduction describing periodontal disease, MMPs/TIMPs, cigarette smoke, and 
their connection to each other.  Chapter two describes the materials and methods of the 
three projects: project one investigated the non-toxic concentrations of CSC and their 
effects on HGF mediated-collagen degradation; project two compared the effects of CSC 
on the HGF-mediated-collagen degradation ability with those of nicotine; and project 
three investigated the combined effects of CSC and P. gingivalis supernatant on HGF-
mediated-collagen degradation. Chapter three describes the results of three projects.  
Chapter four is the discussion.  Chapter five concludes this dissertation and summarizes 
the collective significance of the data from these three studies.  It also describes future 
directions for continuing research in this important area. 
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Table 1.1. Classification of the matrix metalloproteinase family 
Collagenases MMP-1, MMP-8, MMP-13, and MMP-18 
Gelatinases MMP-2 and MMP-9 
Stromelysins MMP-3, MMP-10, and MMP-11 
Membrane-type MMPs 
(MT-MMPs) 
MMP-14, MMP-15, MMP-16, MMP-17, MMP-24, and 
MMP-25 
Minimal-domain MMPs MMP-7 and MMP-26 
Others MMP-12, MMP-19, MMP-20, MMP-21, MMP-22,  MMP-




Material and Methods 
 
Cell Culture  
HGFs were cultured from explants of clinically healthy gingival connective tissue 
removed from a non-smoking patient undergoing crown-lengthening surgery as described 
previously (Zhang et al., 2009) at Indiana University School of Dentistry with Indiana 
University Purdue University Indianapolis (IUPUI) Institutional Review Board (IRB) 
approval (0609-60) and informed patient consent was obtained for the use of human 
gingival tissues.  Briefly, the tissue was transported from the clinic to the laboratory in 
phosphate buffered saline (PBS) solution, washed with 70% ethanol, and rinsed in PBS to 
remove the ethanol.  The washing and rinsing steps were repeated and then the tissues 
were minced into small fragments of approximately 1 mm3.  The tissue pieces were then 
placed in cell culture dishes, air-dried, and incubated for 5-7 days at 37°C and 5% CO2 in 
low glucose (1 g/L) Dulbecco’s Modified Eagle’s Media (DMEM) (Hyclone, Logan, 
Utah) supplemented with 15% fetal bovine serum (FBS) (Hyclone), 4 mM L-glutamine 
(Hyclone), 100 U/ml penicillin (Invitrogen, Carlsbad, CA), 50 µg/ml 
gentamicin(Invitrogen), and 2.5 µg/ml fungizone (Invitrogen).  The cells that grew out of 
the explants were subcultured and maintained.  Cells at passage 3 to 8 were utilized in 
these experiments.   
 16
Bacterial Growth and Culture Supernatant 
The P. gingivalis ATCC 33277 supernatant was provided as a gift from Dr. J. Katz 
(University of Alabama at Birmingham School of Dentistry, Birmingham, AL).  P. 
gingivalis was cultured on enriched trypticase soy agar plates with 3% sheep blood and 
then in brain heart infusion broth with 1 mg/ml of cysteine, 5 µg/ml of hemin, and 0.5 
µg/ml of menadione (supplemented brain heart infusion broth) as described previously 
(Zhou and Windsor, 2006).  P. gingivalis were incubated in an anaerobic chamber (Coy 
Laboratories, Ann Arbor, MI) with an atmosphere of 85% nitrogen, 10% hydrogen, and 
5% carbon dioxide. When the bacterial growth yielded an OD660 of 1.0-1.2, the culture 
supernatant was collected at 13,000 g for 20 min at 4°C.  The collected supernatant was 
then filtered twice through 0.2 µm membranes and stored at -20°C until utilized. 
 
Measurement of HGF Proliferation by Water-soluble Tetrazolium-1 (WST-1) 
Assays in the Different Treatment Conditions 
Mitochondrial dehydrogenase activities were measured using the WST-1 assay (Roche 
Applied Science, Penzberg, Germany) as described previously (Zhang et al., 2009).  
HGFs were detached by incubation for 5 min with 0.25% trypsin (Invitrogen), pelleted, 
resuspended in DMEM with 15% FBS, and then seeded (75,000 cells/well) in 6-well 
plates with 2 ml DMEM with 15% FBS.  The plates were incubated for 24 hours to allow 
the cells to attach.  The media were then removed and the HGFs exposed to 1 ml serum-
free DMEM with different chemicals according to project conditions (Table 2.1.1, Table 
2.2.1, and Table 2.3.1).  The positive control was untreated HGFs and the negative 
control was serum-free DMEM without cells.  After 72 hours, the media in the 6-well 
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plates was removed and the cells washed with 2 ml serum-free DMEM three times for 15 
minutes.  Cell proliferation reagent WST-1 (100 µl WST-1 and 900 µl serum-free 
DMEM) was added and the plate incubated for 2 hours at 37°C and 5% CO2.  A 100 µl 
sample from each well of the 6-well plates were placed into a 96-well plate and the 
absorbance values of the samples against the negative control as the blank were measured 
using a microplate reader (Titertek, Multiskan MCC, Flow Laboratories, Mclean, VA) at 
450 nm.  The experiments were repeated three to four times and the mean value 
calculated.  The absorbance values of each sample were compared with the untreated cell 
control by percentage in the following equation: 
 
Cell proliferation (%) = (absorbance value of CSC treatment/absorbance value of no CSC 
treatment) ×100% 
 
Measurement of Cytotoxicity on HGFs by Lactate Dehydrogenase (LDH) Assays in 
the Different Treatment Conditions 
Cellular membrane integrity was monitored using the permeability assay based on the 
determination of the release of LDH into the media.  The Cytotoxicity Detection KitPLUS 
(Roche Applied Science, Mannheim, Germany), which measures the conversion of 
tetrazolium salt into a red formazan product, was used as described previously (Zhang et 
al., 2009).  Cells were treated with 1 ml serum-free DMEM with different chemicals 
according to project conditions (Table 2.1.1, Table 2.2.1, and Table 2.3.1).  The high 
control (total cell death) were generated by adding 1.9 ml of serum-free DMEM and 100 
µl lysis solution to the control cells as described by the manufacturer after 72 hours, 
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which gave the maximum release of LDH.  The low control consisted of serum-free 
DMEM from the untreated control cells after 72 hours and gave the minimal release of 
LDH.  Serum-free DMEM without HGFs was utilized as the background level of the 
assay.  After 72 hours, media from each of the wells was transferred to a 96-well plate 
and 100 µl of reconstituted mix, as per the manufacturer (Roche), was added to each well 
and the plates incubated for 15 minutes at room temperature.  Absorbance was recorded 
at 490 nm in a microplate reader (Titertek, Multiskan MCC, Flow Laboratories, Mclean, 
VA).  The experiments were repeated three to four times and the mean value calculated.  
The percentage release of LDH from the treated cells was calculated by comparing it to 
the maximum release of LDH.  To determine the cytotoxicity, the absorbance values of 
the background were subtracted from that of the experimented samples and the 
cytotoxicity was calculated by the following equation: 
 
Cytotoxicity (%) = (experiment value-low control)/ (high control–low control) ×100%  
 
Collagen Degradation Assays 
The collagen degrading ability of the HGFs was determined with a reconstituted collagen 
type I assay system as previously described by Birkedal-Hansen et al. (Birkedal-Hansen 
et al., 1984).  Briefly, rat tail tendon type I collagen was dissolved in 13 mM HCl and 
then mixed rapidly on ice with one-fifth volume of a neutralizing phosphate buffer 
(prepared as follows: 40 ml of 0.2 M NaH2PO4/Na2HPO4, pH 7.4, 40 ml 0.1 M NaOH, 8.3 
ml 5 M NaCl) to yield a final collagen concentration of 300 µg/ml.  Aliquots of 1.5 
ml/well (450 µg collagen/well) were dispensed in 6-well plates and incubated at 37°C for 
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2 hours.  The collagen gels were dehydrated overnight in a laminar flow hood, washed 3 
times for 30 min with sterile water, and then air-dried in the hood.  Trypsin was used to 
assess the quality of collagen.  Trypsin was not capable of cleaving the collagen, thus 
demonstrating that it was native and not denatured (data not shown).  HGFs at 90% 
confluence were detached with 0.25% trypsin, pelleted, resuspended in DMEM with 
serum, and then seeded as single colonies (75,000 cells/well) in the center of a 6-well 
plate coated with collagen.  After the cells attached, 2 ml serum-free DMEM with the 
different chemicals was added according the project requirements (Table 2.1.1, Table 
2.2.1, and Table 2.3.1).  Serum-free medium were utilized as experimental controls.  
After certain treatment periods according to different project conditions (Table 2.4), the 
cells were removed with 500 µl of 0.1% Triton X-100 and 200 µl of 0.25% trypsin 
(Invitrogen, Carlsbad, CA).  The wells were then stained with Coomassie blue to 
visualize the collagen cleavage.  The 6-well plates were scanned using the NIH Scion 
Image software (Scion Corporation, Frederick, MD) to measure the collagen degradation 
(the size of measurement area was defined by maximal collagen degraded area) and the 
average optical density (OD) value of collagen degradation area was determined.  The 
average background values of each 6-well plate were subtracted from each OD value.  
The final OD values were compared to the control value (untreated group), and finally 
the relative value for each group was calculated by setting all the control to one.  The 




HGFs were cultured in serum-free DMEM  (Hyclone, Logan, Utah) with the different 
chemicals according the project conditions (Table 2.1.1, Table 2.2.1, and Table 2.3.1).  
After three or five days (Table 2.5), the conditioned media from the HGF cells were 
collected.  The cell membrane extracts were then prepared utilizing the Mem-PER 
Eukaryotic Membrane Protein Extraction Regent Kit (Pierce, Rockford, IL) and the 
PAGEprepTM Protein Clean-Up and Enrichment Kit (Pierce, Rockford, IL).  The 
concentrations of total protein in the concentrated media and membrane extracts were 
determined according to the Bio-Rad protein assay protocol (Bio-Bad Laboratories, 
Hercules, CA).  The same amount of concentrated HGF media and membrane extracts by 
protein levels were mixed with non-reducing loading buffer (without β-mercaptoethanol) 
and resolved at 200 V in 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) gels copolymerized with 1 mg/ml gelatin.  The gels were then washed with 
solution 1 (50 mM Tris, pH 7.5, 3 mM NaN3, 2.5% Triton X-100), solution 2 (50 mM 
Tris, pH 7.5, 3 mM NaN3, 5 mM CaCl2, 1 µM ZnCl2,  2.5% Triton X-100), and solution 
3 (50 mM Tris, pH 7.5, 3 mM NaN3, 5 mM CaCl2, 1 µM ZnCl2) for 20 minutes each.  
The gels were then incubated in fresh solution 3 at 37°C overnight and then stained with 
Coomassie blue to visualize the proteolytic bands.  The gelatin gels were scanned using 
the NIH Scion Image software to measure the gelatin degradation (the size of 
measurement area was defined by maximal gelatin degraded area) and the average OD 
value of gelatin degradation area was determined.  The average background values of 
each gels were subtracted from each OD value.  The final OD values were compared to 
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the control value (untreated group) and finally the relative value for each group was 
calculated by setting all of the controls to one.  The experiments were repeated 3 times. 
 
Western Blots Analyses 
HGFs were cultured for three days or five days in serum-free DMEM with the different 
chemicals according the project conditions (Table 2.1.1, Table 2.2.1, and Table 2.3.1).  
The conditioned media were then collected and concentrated, and the membrane extracts 
(Table 2.6) prepared as described above.  The concentrations of the total protein in the 
concentrated media were determined according to the Bio-Rad protein assay protocol 
(Bio-Bad Laboratories, Hercules, CA).  The same amount of total protein of untreated 
and CSC treated concentrated media was resolved in 10% SDS-PAGE gels at 200 V.  
The proteins on the gels were transferred to polyvinylidene fluoride (PVDF) membranes 
at 0.08 amps overnight using blotting buffer (2 mM Tris-HCl, pH 8.3, 192 mM glycine, 
and 10% methanol).  The membranes were then incubated in 5% milk in PBS solution 
with 0.1% Tween-20 (PBS-T, pH 7.4) (Invitrogen, Carlsbad, CA) for 1 h to block 
nonspecific binding.  The membranes were then incubated with primary antibodies at 4°C 
for overnight.  The primary antibodies utilized in the study were described in Table 2.7 
and Table 2.8.  The membranes were then washed three times with PBS-T and incubated 
with anti-mouse or anti-rabbit secondary antibodies (Amersham, Piscastaway, NJ) for 1h 
at room temperature.  The membranes were then developed with the ECLTM (kit 
Amersham, Piscastaway, NJ) according to the manufacturer’s protocol.  The blots 
exposed X-ray films were scanned using the NIH Scion Image software to measure the 
bands (the size of measurement area was defined by maximal detected band) and the 
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average OD value of the detected antibody band area was determined.  The average 
background values of each X-ray film were subtracted from each OD value.  The final 
OD values were compared to the control value (untreated group) and finally the relative 
value for each group was calculated by setting all of the controls to one.  The Western 
blots were repeated 3 times. 
 
Reverse Transcription PCR (RT-PCR) 
To determine the mRNA levels of MMPs and TIMPs (Table 2.10) expressed by the 
HGFs treated with the different agents for 48 hours (Table 2.1.1, Table 2.2.1, and Table 
2.3.1), the total RNA was extracted using the Qiagen mini kit (Qiagen, Valencia, CA).  
The mRNA and primers (Zhou and Windsor, 2006) were mixed with the Qiagen OneStep 
RT-PCR mix (Qiagen, Valencia, CA) according to the manufacturer’s protocol (Table 
2.9).  RT-PCR was performed using a Bio-Rad iCycler (Bio-Bad Laboratories, Hercules, 
CA).  The reverse transcription was accomplished at 50°C for 30 min and terminated at 
95°C for 15 min.  PCR was then performed for 30 cycles with denaturation at 95°C, 
annealing at 50°C, and extension at 72°C for 1 min each.  The PCR products were then 
resolved in 0.8% w/v agarose gels at 120 V and stained with ethidium bromide.  The gels 
were photographed under ultraviolet light and then analyzed with the NIH scion Image 
software (Version beta 4.03).  The cyclophilin bands were utilized for standardization of 
the RT-PCR results.  The relative mRNA expression levels of the treated and untreated 
cells were then determined.  The experiments were repeated 3 times. 
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Statistical Analyses  
The data were presented as mean and standard deviation (SD).  Statistical analyses were 
performed by One-way Analysis of Variance (ANOVA) and the Tukey’s test in the 
Statistical Package for Social Science (SPSS) 11.5 (SPSS Inc., Chicago, IL) (Zhou et al., 
2007).  The level of significant was set at p<0.05. 
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Table 2.1. Treatment conditions for project one 
Treatments 
800 µg/ml CSC 
400 µg/ml CSC 
200 µg/ml CSC 
100 µg/ml CSC 
50 µg/ml CSC 
25 µg/ml CSC 
12.5 µg/ml CSC 
6.25 µg/ml CSC 
3.125 µg/ml CSC 
0 µg/ml CSC 
 
CSC: cigarette smoke condensate (Murty Pharmaceuticals, Lexington, KY) diluted in 
serum-free DMEM. 
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Table 2.2. Treatment conditions for project two 
Treatments 
100 µg/ml CSC 
2.4 µg/ml Nicotine 
0 µg/ml 
 
CSC: cigarette smoke condensate (Murty Pharmaceuticals, Lexington, KY) diluted in 
serum-free DMEM.  Nicotine (Sigma Chemical Co., St. Louis, MO) diluted in serum-free 
DMEM.  The percentage of nicotine in the CSC was determined to be 2.4% by the 
Clinical Pharmacology Laboratory (San Francisco General Hospital, San Francisco, CA). 
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Table 2.3. Treatment conditions for project three 
Treatments 
100 µg/ml CSC plus 10% (v/v) P. gingivalis supernatant 
50 µg/ml CSC 
10% (v/v) P. gingivalis supernatant 
50 µg/ml of CSC plus 10% (v/v) P. gingivalis supernatant 
0 µg/ml CSC 
 
CSC: cigarette smoke condensate (Murty Pharmaceuticals, Lexington, KY) diluted in 
serum-free DMEM.  For gelatin zymography, collagen degradation assay, Western blots, 
and RT-PCR, 50 µg/ml CSC plus 10% (v/v) P. gingivalis supernatant has not be used as 
treatment because its cytotoxicity to HGFs. 
 27
Table 2.4. Treatment periods of collagen degradation assays for the different projects 
Project Treatment Periods 
Project one 3 days 
Project two 3 days 
Project three 1, 3, 5, and 7 days 
 
In project three, a synthetic MMP inhibitor (GM6001, 100 nM, Chemicon, Temecula, 
CA) were utilized in the inhibition experiments. 
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Table 2.5 Samples for gelatin zymography in the different projects  
Project Treatment Periods 
Project one Conditioned media and cell membrane extracts at three days 
Project two Conditioned media and cell membrane extracts at three days 
Project three Conditioned media at five days 
 
In project two, a MMP inhibitor, 1, 10-phenothroline (10 mM) (Sigma-Aldrich, St. Louis, 
MO), was utilized in the inhibition experiments. 
 29
Table 2.6. Samples for Western blots in the different projects  
Project Treatment Periods 
Project one Conditioned media and cell membrane extracts at three days 
Project two Conditioned media and cell membrane extracts at three days 
Project three Conditioned media and cell membrane extracts at five days 
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Table 2.7. MMPs and TIMPs antibodies used in the Western blots  
Anitibody Clone Company Concentrations 
monoclonal MMP-1 (Ab-5) Clone III 12b Neomarkers, Fremont, CA 5 µg/ml 
monoclonal MMP-2 (Ab-2) Clone V B3 Neomarkers, Fremont, CA 5 µg/ml 
monoclonal MMP-3 (Ab-2) Clone II D4 Neomarkers, Fremont, CA 5 µg/ml 
polyclonal MMP-14 AB8221 Chemicon, Temecula, CA 0.3 µg/ml 
monoclonal TIMP-1 (Ab-1) Clone 102B1 Neomarkers, Fremont, CA 5 µg/ml 
monoclonal TIMP-2 (Ab-1) Clone T2-101 Neomarkers, Fremont, CA 5 µg/ml 
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Table 2.8. MMPs and TIMPs detected in the Western blots in the different projects 
Project Treatment Periods 
Project one MMP-1, -2, -3, and -14; TIMP-1 and -2. 
Project two MMP-2 and -14; TIMP-2. 
Project three MMP-1, -2, -3, and -14; TIMP-1 and -2. 
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Table 2.9. RT-PCR primers for cyclophilin, MMPs and TIMPs 
mRNA Primer 
Cyclophilin (247 bp): (f)CCGTGTTCTTCGACATT 
 (r)GCCAGGACCCGTATGCT 
MMP-1/collagenase-1 (721 bp): (f)GAAGTTGATGAAGCAGCCCAGATGT 
 (r)CAGTTGTGGCCAGAAAACAGAAGTGAAA
MMP-2/gelatinase-A (364 bp): (f)ATCCGTGGTGAGATCTTCTTCTT 
 (r)AGCCAGGATCCATTTTCTTCTT 
MMP-3/stromelysin-1 (659 bp): (f)GACACCAGCATGAACCTTGTT 
 (r)GGAACCGAGTCAGGTCTGTG 
MMP-14/MT1-MMP (670 bp): (f)GATAAACCCCAAAAACCCCACCTA 
 (r)CCCTCCTCGTCCACCTCAATG 
TIMP-1 (534 bp): (f)CCTTCTGCAATTCCGACCTCGTC 
 (r)CGGGCAGGATTCAGGCTATCTGG 
TIMP-2 (433 bp): (f)TGGAAACGACATTTATGGCAACC 
 (r)ACAGGAGCCGTCACTTCTCTTGAT 
 






Table 2.10. MMPs and TIMPs detected by RT-PCR in the different projects 
Project Treatment Periods 
Project one None 
Project two MMP-2, and -14; TIMP-2. 






Project One: Cigarette Smoke Condensate Affects the Collagen-Degrading Ability of 
Human Gingival Fibroblasts 
 
Morphology of the HGFs  
The HGFs attached and spread rapidly to take on a typical long spindle-shaped parallel 
alignment appearance in the 6-well plate without CSC (Figure 3.1.1).  At low CSC 
concentrations, the HGFs remained normal in appearance (Figure 3.1.2).  In contrast, 
CSC-treated HGFs showed a rounded appearance with a haphazard arrangement and 
detached from the 6-well plate at the higher concentrations (above 200 µg/ml; Figure 
3.1.3).  When the concentrations reached 800 µg/ml, almost no HGFs were still attached 
(data not shown). 
 
Measurement of the Cell Proliferation by WST-1 
After exposure to CSC at 800 µg/ml, 400 µg/ml, 200 µg/ml, 100 µg/ml, 50 µg/ml, 25 
µg/ml, 12.5 µg/ml, 6.25 µg/ml, and 3.125 µg/ml, the amount of cell proliferation was 
6.86±5.36%, 7.32±5.49%, 46.79±26.39%, 90.29±42.43%, 81.56±24.71%, 
80.43±29.36%, 64.85±30.10%, 60.09±12.92%, and 81.85±38.24%, respectively, when 
compared to the untreated control HGFs (100%; Figure 3.1.4).  Overall, the CSC had a 
negative effect on the growth of the HGFs compared to the control.  However, various 
concentrations of the CSC had different effects on the growth of the HGFs.  There were 
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no concentration dependent relationship between the CSC concentrations and negative 
effects at CSC concentrations less than 200 µg/ml.  When the concentration of CSC 
reached 200 µg/ml, cell proliferation was reduced to 46.79% and decreased significantly 
when compared to the untreated HGFs (p=0.023).  
 
Measurement of Cytotoxicity of HGFs by LDH 
Generally, the CSC had a toxic effect on the growth of HGFs despite some variations 
(Figure 3.1.4).  After exposure to CSC at 800 µg/ml, 400 µg/ml, 200 µg/ml, 100 µg/ml, 
50 µg/ml, 25 µg/ml, 12.5 µg/ml, 6.25 µg/ml, and 3.125 µg/ml, the amount of cytotoxicity 
was 70.43±11.13%, 32.42±24.62%, 10.59±16.44%, 10.93±19.66%, 8.97±17.22%, 
-0.80±4.52%, 4.43±10.356%, 1.23±6.49%, and 4.22±4.25%, respectively (Figure 3.1.5).  
The CSC at concentrations of 400 µg/ml and 800 µg/ml demonstrated significant toxic 
effects on the HGFs (p=0.001 and p=0.000, respectively)  
 
Collagen Degradation  
Untreated HGFs (control) cleaved the collagen underneath the cell colonies and formed a 
small transparent area (Figure 3.1.6).  At low concentrations of CSC (≤ 25 µg/ml), the 
area of collagen degradation increased a little but was not statistically significant (Figure 
3.1.7) (p>0.05).  This increase in collagen degradation was especially evidence when the 
concentration of CSC reached 100 µg/ml (p=0.002).  When the concentration of CSC 
reached 200 µg/ml or higher, the collagen degrading ability decreased probably as a 




In the HGF conditioned media with or without CSC, gelatinase-A (MMP-2, 72/62kDa) 
bands were detected (Figure 3.1.8).  The proMMP-2 (72kDa) production at low 
concentrations of CSC (≤100 µg/ml) showed little differences among the various 
concentrations of CSC (Table 3.1.1).  At high concentrations of CSC (≥200 µg/ml), the 
levels of both the pro and active forms of MMP-2 decreased compared to the untreated 
HGFs.  However, at low concentrations of CSC (≤100 µg/ml), the active form of MMP-2 
(62kDa) increased with increasing CSC concentrations.  This increase was especially 
evident when the concentration of CSC reached 25 µg/ml.  Furthermore, MMP-9 
(gelatinase B) could not be detected by zymography (data not shown).  
 
In the HGF membrane extracts with or without CSC, gelatinase-A (MMP-2, 72/62kDa) 
bands were detected (Figure 2.9).  The proMMP-2 (72kDa) production was not much 
different among the various concentrations of CSC (Table 3.1.2).  However, the active 
form of MMP-2 (62kDa) increased more than 16-fold compared to the control at 
concentrations above 50 µg/ml.  The production of MMP-9 (gelatinase B) could not be 
detected by zymography of the membrane extracts (data not shown).  
 
Western Blots Analyses 
Both pro-MMP-1 (52 kDa) and active MMP-1 (42 kDa) were detected in the conditioned 
media (Figure 3.1.10).  Compared to the control group, the highest levels of both pro and 
active MMP-1 were produced when the concentration of CSC was 100 µg/ml (Table 
3.1.3). 
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In the HGF conditioned media with or without CSC, gelatinase-A (MMP-2, 72/62kDa) 
bands were detected (Figure 3.1.10).  Similar to the results of the zymography, the 
proMMP-2 (72kDa) production increased at 25 and 50 µg/ml CSC, and decreased at 800 
µg/ml.  At other concentrations of CSC, proMMP-2 showed little differences (Table 
3.1.3).  At 25, 50, and 100 µg/ml CSC, the active form of MMP-2 (62kDa) increased 
with increasing CSC concentrations.  At higher concentrations of CSC (400 and 800 
µg/ml), the active form of MMP-2 (62kDa) decreased.  In the HGF membrane extracts 
with or without CSC, gelatinase-A (MMP-2, 72/62kDa) bands were detected (Figure 
3.1.11).  The proMMP-2 (72kDa) production increased at higher concentrations of CSC 
(≥25 µg/ml) (Table 3.1.4).  However, the active form of MMP-2 (62kDa) increased more 
than 2.8 folds at CSC treated concentrations ≥3.125 µg/ml compared to the control. 
 
ProMMP-3 (59/54 kDa) were detected in the conditioned media at all the different 
concentrations of the CSC and the active forms of MMP-3 (49/44 kDa) were also 
detected (Figure 3.1.10 and Table 3.1.3).  However, the production of the active form of 
MMP-3 decreased sharply compared to control above 100 µg/ml and this may be due to 
cell death. 
 
MMP-14 (64 kDa) was also detected in the conditioned media.  Compared with the 
control group, CSC increased the production of MMP-14 at concentrations of 12.5 µg/ml 
and 200 µg/ml (Figure 3.1.10; Table 3.1.3).  However, the production of MMP-14 
increased more than 2-fold in the membrane extracts from HGFs at the concentration of 
50 µg/ml (Figure 3.1.11; Table 3.1.4).  
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TIMP-1 (28.5 kDa) levels in the conditioned media increased at concentrations of CSC at 
and above 6.25 µg/ml.  Generally, increasing CSC concentrations led to increased 
production of TIMP-1 compared to the control until cytotoxicity occurred (Figure 3.1.10; 
Table 3.1.3).  
 
Generally, TIMP-2 (21 kDa) production in the conditioned media decreased with 
increasing concentrations of CSC (Figure 3.1.10; Table 3.1.3).  However, TIMP-2 
presence in the HGF membrane extracts increased at the concentrations of 50 and 100 
µg/ml (Figure 3.1.11; Table 3.1.4).  TIMP-2 levels in the membrane extracts decreased at 
and above 200 µg/ml. 
 Table 3.1.1. Expression of MMP-2 in HGF conditioned media at the different CSC concentrations  
compared to the control by gelatin zymography 
 
* denotes significant differences from control value at p<0.05 


















proMMP-2 1.300.34 1.120.20 0.930.22 1.771.13* 1.761.21* 1.450.81* 0.640.50 0.440.25* 0.260.15*
MMP-2 1.090.08 1.230.09 0.800.22 1.620.53* 1.440.10* 1.430.28* 0.830.40 0.430.30* 0.300.10*
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 Table 3.1.2. Expression of MMP-2 in HGF membrane extracts at the different CSC concentrations  
compared to the control by gelatin zymography 
 
























proMMP-2 1.250.02 1.260.21 1.270.03 1.070.02 1.400.02 1.680.05* 0.930.03 1.250.05
MMP-2 5.680.29* 5.360.59* 8.870.88* 5.191.52* 16.642.20* 31.882.62* 23.732.32* 27.162.86*
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 Table 3.1.3. Expression of MMPs and TIMPs in HGF conditioned media at the different CSC concentrations  
compared to the control by Western blots 
 
* denotes significant differences from control value at p<0.05 
 3.125 μg/ml 6.25 μg/ml 12.5 μg/ml 25 μg/ml 50 μg/ml 100 μg/ml 200 μg/ml 400 μg/ml 800 μg/ml 
proMMP-1 0.800.04 0.980.03 1.220.02 0.860.06 0.720.04 1.430.07* 1.040.07 1.560.06* 0.930.01
MMP-1 0.770.03 1.280.05 1.170.03 0.950.03 0.770.06 1.350.07 0.650.02 0.940.02 0.890.05 
proMMP-2 1.260.43 1.100.29 0.880.32 1.471.03* 1.441.01* 1.390.34 0.760.40 0.590.35 0.270.25*
MMP-2 1.180.18 1.090.19 1.120.42 1.960.43* 1.810.31* 1.440.18* 0.960.41 0.270.32* 0.200.15*
proMMP-3 1.050.02 1.040.02 1.140.02 1.140.05 0.930.04 1.210.06 1.170.08 0.960.03 0.890.06
MMP-3 0.960.01 0.800.02 0.900.02 0.940.02 0.800.03 0.900.11 0.220.02* 0.110.01* 0.150.01*
MMP-14 1.090.01 1.080.06 1.970.09 1.170.06 1.200.02 1.570.04* 1.290.02 1.180.04 1.190.11 
TIMP-1 1.340.01 3.490.04* 4.560.06* 4.350.05* 5.910.05* 6.450.05* 6.200.16* 3.830.09* 5.590.09*
TIMP-2 1.280.01 1.020.02 0.970.06 0.920.04 0.410.02* 0.310.04* 0.400.02* 0.440.02* 0.340.01*
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Table 3.1.4. Expression of MMP-2, MT1-MMP, and TIMP-2 in HGF membrane extracts at the different CSC concentrations 
compared to the control by Western blots 
 




















proMMP-2 1.180.12 1.570.71 1.410.23 1.660.32* 1.820.22* 2.110.15* 2.190.63* 1.650.25*
MMP-2 2.860.29* 3.010.59* 4.480.88* 4.361.02* 4.081.29* 5.521.92* 4.821.32* 3.121.56*
MMP-14 0.970.02 1.040.03 0.790.06 1.130.06 2.130.14* 1.230.03 1.670.06* 0.780.05
TIMP-2 1.460.05 1.500.11* 1.740.12* 1.020.03 2.980.13* 2.470.11* 0.880.04 0.090.01*
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Figure 3.1.1. CSC-free HGFs (negative control).  HGFs attached to the plate displayed a 
typical long spindle-shaped parallel alignment appearance (magnification ×100).   
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Figure 3.1.2. 3.125 µg/ml CSC-treated HGFs.  HGFs displayed a normally typical long 
spindle-shaped parallel alignment appearance (magnification ×100).   
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Figure 3.1.3. 200 µg/ml CSC-treated HGFs.  HGFs displayed a round appearance with a 




Figure 3.1.4. Cell proliferation (%) of CSC-treated HGFs.  The cell proliferation of CSC 
treated HGFs was lower than that of the untreated HGFs.  Data were analyzed by one-
way ANOVA and Tukey’s test multiple comparison tests: * denotes significant 
differences from control value at p<0.05. 
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Figure 3.1.5. Cytotoxicity (%) of CSC-treated HGFs.  The cytotoxicity of CSC treated 
HGFs was higher than that of CSC-free HGFs.  Data were analyzed by one-way ANOVA 
and Tukey’s test multiple comparison tests.  * denote significant differences from control 
value at p<0.05. 
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Figure 3.1.6. Effects of the different concentrations of CSC (0-800 µg/ml) on the 
collagen-degrading ability of HGFs.  
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Figure 3.1.7. The statistical analyses of HGFs at the different concentrations of CSC (0-
800 µg/ml) treatment compared to the control group (without CSC).  Data were analyzed 
by one-way ANOVA and Tukey’s test multiple comparison tests.  * denotes significant 
differences from control value at p<0.05. 
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Figure 3.1.8. Gelatin zymography of the HGF-conditioned media treated with the 
different concentrations of CSC (0-800 µg/ml) for 72 hours.  
 
 51
Figure 3.1.9. Gelatin zymography of membrane extracts from the HGFs treated with the 
different concentrations of CSC (0-400 µg/ml) for 72 hours.  
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Figure 3.1.10. Western blots analyses for selected MMPs and TIMPs in HGF-conditioned 
media treated with the different concentrations of CSC (0-800 µg/ml) for 72 hours.  
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Figure 3.1.11. Western blots analyses for MMP-2, MMP-14 and TIMP-2 in the 
membrane extracts from HGFs treated with the different concentrations of CSC (0-400 




Project Two: Effects of Cigarette Smoke Condensate and Nicotine on Human Gingival 
Fibroblast-mediated Collagen Degradation  
 
Collagen Degradation  
Cell morphology was examined every 24 hours.  The HGFs displayed normal long 
spindle-shaped parallel alignment (data not shown) during the three days of treatment 
with 100 µg/ml CSC or 2.4 µg/ml nicotine. CSC at the concentration of 100 µg/ml 
significantly increased the collagen degradation of HGFs at 72 hours (1.57±0.48 fold, 
p=0.011) when compared to the control.  However, nicotine at a concentration of 2.4 
µg/ml did not alter the collagen cleaving ability of the HGFs (1.01±0.29 fold, p=0.99) 
(Figure 3.2.1 and 3.2.2). 
 
Gelatin Zymography 
Pro and active MMP-2 (72/62 kDa, respectively) bands were detected in the HGF 
conditioned media (Figure 3.2.3 and 3.2.4).  No significant difference in the pro-MMP-2 
(72 kDa) protein levels were detected with the different treatments (p>0.05).  The active 
MMP-2 (62 kDa) levels increased in the media of the CSC-treated group (1.93±0.55 fold, 
p=0.04) when compared to the control.  However, active MMP-2 did not significantly 
increase in the nicotine-treated group (1.22±0.18 fold, p=0.72).   
 
Pro and active MMP-2 (72/62 kDa) were detected in the HGF membrane extracts (Figure 
3.2.5 and 3.2.6).  The proMMP-2 (72 kDa) levels were not altered in the CSC or nicotine 
treatment groups (1.21±0.19 fold, p=0.49 and 1.42±0.31 fold, p=0.11, respectively).  
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Active MMP-2 (62 kDa) increased significantly in the CSC-treated group (5.24±1.42 
fold, p=0.002) when compared to the control.  There was no significant difference in the 
level of active MMP-2 in the HGF membrane extract of the nicotine treated group 
(1.01±0.29 fold, p=0.99) when compared to the control.  
 
Western Blots Analyses 
Pro-MMP-2 (72 kDa), active MMP-2 (62 kDa), MMP-14 (64 kDa) and TIMP-2 (21 kDa) 
were all detected in the conditioned media (Figure 3.2.7 and 3.2.8).  CSC increased the 
level of active MMP-2 (1.36±0.18, p=0.043) when compared to the control group.  
However, CSC did not alter the levels of pro-MMP-2, MMP-14 and TIMP-2 (1.16±0.27 
fold, p=0.42; 1.11±0.04 fold, p=0.068; and 0.71±0.67 fold, p=0.69, respectively) in the 
conditioned media.  Nicotine did not alter the levels of pro-MMP-2, active MMP-2, 
MMP-14 and TIMP-2 (0.95±0.23 fold, p=0.93; 0.95±0.31 fold, p=0.91; 0.98±0.09 fold, 
p=0.89; and 1.00±0.5 fold, p=1.00, respectively) in the conditioned media.   
 
Pro-MMP-2 (72 kDa), active MMP-2 (62 kDa), MMP-14 (64 kDa) and TIMP-2 (21kDa) 
were detected (Figure 3.2.9 and 3.2.10) in the membrane extracts from the HGFs.  CSC 
increased the levels of active MMP-2, MMP-14, and TIMP-2 (1.56±0.17 fold, p=0.003; 
1.57±0.19 fold, p<0.001; and 1.82±0.73 fold, p=0.019, respectively) in the HGF 
membrane extracts when compared to the control group.  However, nicotine did not 
significantly affect the levels of proMMP-2, active MMP-2, MMP-14, and TIMP-2 
(1.10±0.19 fold; p=0.62; 1.09±0.031 fold, p=0.79; 1.04±0.12 fold, p=0.92; and 1.30±0.48 
fold, p=0.53, respectively) when compared to the control.   
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RT-PCR 
MMP-2, MMP-14 and TIMP-2 mRNA levels in the 100 µg/ml CSC treated HGFs 
increased 2.11±0.13 (p=0.02), 1.85 ±0.17 (p<0.001) and 2.01± 0.04 (p<0.001) folds, 
respectively, when compared to the control (Figure 3.2.11 and 3.2.12).  However, 
nicotine (2.4 µg/ml) did not significantly alter the mRNA levels of MMP-2, MMP-14 and 
TIMP-2 when compared to the control group (1.62±0.07 fold, p=0.10; 0.90±0.01 fold, 
p=0.257; and 1.65±0.02 fold, p=0.09, respectively).   
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Figure 3.2.1. Effects of CSC (100 µg/ml) and nicotine (2.4 µg/ml) on the collagen-
degrading ability of the HGFs.   
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Figure 3.2.2. The graphic representation of the treated HGFs compared to the control 
HGFs on their collagen-degrading ability.  * denotes significant difference, p<0.05. 
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Figure 3.2.3. Gelatin zymography of conditioned media from HGFs treated with CSC 
(100 µg/ml) or nicotine (2.4 µg/ml) for 72 hours.   
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Figure 3.2.4. The graphic representation of gelatin zymography of conditioned media 
from treated HGFs compared to the control HGFs.  * denotes significant difference, 
p<0.05.   
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Figure 3.2.5. Gelatin zymography of the membrane extracts from HGFs treated with CSC 
(100 µg/ml) and nicotine (2.4 µg/ml) for 72 hours.   
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Figure 3.2.6. The graphic representation of gelatin zymography of the membrane extracts 




Figure 3.2.7. Western blots analyses for MMP-2, MMP-14, and TIMP-2 in conditioned 
media from HGFs treated with CSC (100 µg/ml) or nicotine (2.4 µg/ml) for 72 hours.   
 
 64
Figure 3.2.8. The graphic representation of Western blots analyses for MMP-2, MMP-14, 
and TIMP-2 in conditioned media from treated HGFs compared to the control HGFs.  * 
denotes significant difference, p<0.05.   
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Figure 3.2.9. Western blots analyses for MMP-2, MMP-14, and TIMP-2 in the membrane 
extracts from the HGFs treated with CSC (100 µg/ml) or nicotine (2.4 µg/ml) for 72 
hours.   
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Figure 3.2.10. The graphic representation of Western blots analyses for MMP-2, MMP-
14, and TIMP-2 in the membrane extracts from treated HGFs compared to the control 
HGFs. * denotes significant difference, p<0.05. 
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Figure 3.2.11. Effects of CSC (100 µg/ml) or nicotine (2.4 µg/ml) on MMP-2, MMP-14, 
and TIMP-2 mRNA expression.  Cyclophilin (CYP) served as the control.   
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Figure 3.2.12. The graphic representation of MMP-2, MMP-14, and TIMP-2 mRNA 




Project Three: Combined Effects of Cigarette Smoke Condensate and Porphyromonas 
gingivalis on the Collagen Degrading Ability of Human Gingivalis Fibroblasts 
 
Morphology of the HGFs   
The HGFs attached and spread rapidly to take on a typical long spindle-shaped parallel 
alignment appearance in the 6-well plate without CSC at 3 days (Figure 3.3.1).  When 
HGFs was treated with 50 µg/ml of CSC plus 10% (v/v) P. gingivalis supernatant for 3 
days, the HGFs remained normal in appearance (Figure 3.3.2).  However, the number of 
HGFs attached on the wells decreased when treated with 100 µg/ml of CSC plus10% 
(v/v) P. gingivalis supernatant for 3 days (Figure 3.3.3). 
 
Measurement of the Cell Proliferation by WST-1 
After exposure to 50 µg/ml of CSC, 10% (v/v) P. gingivalis supernatant, 50 µg/ml of 
CSC plus 10% (v/v) P. gingivalis supernatant, or 100 µg/ml of CSC plus 10% (v/v) P. 
gingivalis supernatant for 3 days, the amount of cell proliferation was 85.8%, 62.9%, 
82.3%, and 25.8%, respectively, when compared to the untreated control HGFs (100%; 
Figure 3.3.4.).  Overall, 50 µg/ml of CSC, 10% (v/v) P. gingivalis supernatant, and 50 
µg/ml of CSC plus 10% (v/v) P. gingivalis supernatant treatments had no effects on the 
growth of the HGFs when compared to the control (p=0.93, p=0.45, and p=0.88, 
respectively). However, the treatment of 100 µg/ml of CSC plus 10% (v/v) P. gingivalis 
supernatant had a negative effect on cell proliferation (p=0.003).  
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Measurement of Cytotoxicity of HGFs by LDH 
Little effect was observed on the growth of HGFs after exposure to 50 µg/ml of CSC, 
10% (v/v) P. gingivalis supernatant, or 50 µg/ml of CSC plus 10% (v/v) P. gingivalis 
supernatant for 3 days with cytotoxicity of 0.3% (p=0.86), 0.5% (p=0.56), and 5.0% 
(p=0.91), respectively, when compared to the control.  However, after exposure to the 
treatment of 100 µg/ml of CSC plus 10% (v/v) P. gingivalis supernatant, the amount of 
cytotoxicity was 21.8% (p=0.009) (Figure 3.3.5).  
 
Collagen Degradation  
At day 1, almost no collagen degradation was noted among any of four groups (Figure 
3.3.6).  At day 3, untreated HGFs (control) cleaved the collagen underneath the cell 
colonies and formed a small transparent area.  50 µg/ml of CSC or 10% (v/v) P. 
gingivalis supernatant treated HGFs increased the collagen degradation by 1.2 fold and 
1.4-fold, respectively, when compared to the control group. CSC at 50 µg/ml plus 10% 
(v/v) P. gingivalis supernatant treated HGFs increased the degradation of the collagen 1.7 
fold.  At day 5, 50 µg/ml of CSC plus 10% (v/v) P. gingivalis supernatant treated HGF 
degraded all of the collagen in the wells.  At day 7, both 10% (v/v) P. gingivalis 
supernatant treated HGFs and 50 µg/ml of CSC plus 10% (v/v) P. gingivalis supernatant 
treated HGFs degraded all of the collagen in the wells.  The MMP inhibitor (GM6001) 
inhibited collagen degradation by the HGFs treated with CSC at 50 µg/ml plus 10% (v/v) 




Gelatinase-A (MMP-2, 72/62 kDa) bands were detected in the HGF conditioned media 
(Figure 3.3.7).  Both proMMP-2 (72 kDa) and the active form of MMP-2 (62 kDa) were 
detected in all of the treatment groups.  The active form of MMP-2 increased in the 
combined treatment group compared to the other groups.  Furthermore, the production of 
MMP-9 (gelatinase B) could not be detected by zymography (data not shown) and the 
MMP inhibitor (1, 10-phenothroline) inhibited the gelatin degradation in the zymograms 
(Figure 3.3.7).  
 
Western Blots Analyses 
Pro-MMP-1 (57/52 kDa) was detected in the conditioned media from the control and the 
CSC treated HGFs.  Both pro-MMP-1 (57/52 kDa) and active MMP-1 (42 kDa) were 
detected in the conditioned media from the P. gingivalis and CSC plus P. gingivalis 
treated HGFs (Figure 3.3.8).  The 47 kDa active form of MMP-1 was detected in the 
conditioned media from CSC plus P. gingivalis (Figure 3.3.8).  Similar to the results of 
the zymography, the gelatinase-A (MMP-2, 72/62 kDa) bands were detected and the 
active form of MMP-2 (62kDa) protein increased in the treated groups when compared to 
the control group (Figure 3.3.8).  ProMMP-3 (60/54 kDa) were detected in the 
conditioned media of all the samples.  The active forms of MMP-3 (50/44 kDa) were 
detected in the conditioned media from P. gingivalis and CSC plus P. gingivalis treated 
HGFs (Figure 3.3.8).  MMP-14 (64 kDa) was detected in the conditioned media of all the 
samples (Figure 3.3.8).  Both TIMP-1 (28.5 kDa) and TIMP-2 (21 kDa) were detected in 
the conditioned media from all the samples (Figure 3.3.8).  However, TIMP-2 decreased 
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in the treated groups when compared to control group (Figure 3.3.8).  In the cell 
membrane extracts, proMMP-2 (72kDa), MMP-2 (62kDa), MMP-14 (64 kDa) and 
TIMP-2 (21 kDa) were detected in all the groups.  However, there was a lower molecular 
weight fragment of MMP-14 (44 kDa) in the 10% P. gingivalis treated group and CSC 
plus P. gingivalis treated group (Figure 3.3.9). 
 
RT-PCR 
The mRNAs for MMP-1, MMP-2, MMP-3, MMP-14, TIMP-1, and TIMP-2 were 
detected in both the untreated and treated HGFs (Figure 3.3.10).  MMP-1, MMP-2, and 
MMP-14 mRNA levels in the 50 µg/ml of CSC plus 10% (v/v) P. gingivalis supernatant 
treated HGFs all increased about 1.7 fold when compared to the control.  MMP-3 mRNA 
level in 50 µg/ml of CSC plus 10% (v/v) P. gingivalis supernatant treated HGFs 
increased more than 1.4 fold when compared to the control.  Interestingly, the MMP-3 
mRNA level in 50 µg/ml of CSC treated HGFs increased 2.7 fold when compared to the 
control. The TIMP-1 and TIMP-2 mRNA levels in 50 µg/ml of CSC plus 10% (v/v) P. 
gingivalis supernatant treated HGF increased about 1.3 and 1.4 fold, respectively.  The 
other MMP/TIMP mRNA levels in the treated HGFs were basically unchanged when 
compared to the control group (Figure 3.3.11).  
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Figure 3.3.1. Morphology of untreated HGFs (negative control) at 3 days (Bar=50 µm, 
magnification ×100).   
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Figure 3.3.2. Morphology of 50 µg/ml of CSC plus 10% (v/v) P. gingivalis supernatant 
treated HGFs at 3 days (Bar=50 µm, magnification ×100).   
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Figure 3.3.3. Morphology of 100 µg/ml of CSC plus 10% (v/v) P. gingivalis supernatant 
treated HGFs at 3 days (Bar=50 µm, magnification ×100). 
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Figure 3.3.4. Cell proliferation (%) of HGFs by WST-1 at 72 hours.  Results were 
presented as mean and standard deviation (SD).  Error bars represent SD and N=4.  The 




Figure 3.3.5. Cytotoxicity (%) of HGFs by LDH at 72 hours.  Results were presented as 
mean and standard deviation (SD).  Error bars represent SD and N=4.  The level of 
significance was set at p<0.05.  * denote a significant difference compared to the control. 
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Figure 3.3.6. Effects of 50 µg/ml of CSC, 10% (v/v) P. gingivalis supernatant, 50 µg/ml 
of CSC plus 10% (v/v) P. gingivalis supernatant, or 50 µg/ml of CSC plus 10% (v/v) P. 
gingivalis supernatant, as well as 100 nM GM6001, on the collagen-degrading ability of 
HGFs at 1, 3, 5, and 7 days.   
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Figure 3.3.7. Gelatin zymography of the HGF-conditioned media with or without 10 mM 
1, 10-phenothroline.  
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Figure 3.3.9. Western blots analyses for MMP-2, MMP-14, and TIMP-2 in the cell 
membrane extracts of HGFs 
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Figure 3.3.10. Effects of 50 µg/ml of CSC, 10% (v/v) P. gingivalis supernatant, or 50 
µg/ml of CSC plus 10% (v/v) P. gingivalis supernatant on the mRNA expression of 
MMPs and TIMPs.  RT-PCR results of the RNA extracted from untreated HGFs, 50 
µg/ml of CSC, 10% (v/v) P. gingivalis supernatant, or 50 µg/ml of CSC plus 10% (v/v) 
P. gingivalis supernatant treated HGFs for 48 hours.  The cyclophilin bands were utilized 
for standardization of the RT-PCR results.  
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Figure 3.3.11. The graphic representation of 50 µg/ml of CSC, 10% (v/v) P. gingivalis 
supernatant, or 50 µg/ml of CSC plus 10% (v/v) P. gingivalis supernatant on MMP and 
TIMP mRNA expression.  MMP and TIMP mRNA expression levels in different treated 
HGFs compared to control.  The cyclophilin bands were utilized for standardization of 
the RT-PCR results.  Results were presented as mean and standard deviation (SD) and 
N=3.  Error bar represent SD.  The level of significance was set at p<0.05.  * denote a 







Cigarette smoke is a complex mixture that contains more than 6,000 chemicals (Gao et 
al., 2005b).  Nicotine is the addictive agent in tobacco.  According to the manufacturer, 
CSC was prepared from a standard tobacco cigarette (Lee et al., 1976) that was smoked 
with a smoking machine under conditions so as to simulate as closely as possible the 
smoking habits of the average tobacco cigarette smoker.  The cigarette smoke condensate 
(CSC) was captured and dissolved in dimethyl sulfoxide (DMSO) (Lee et al., 1976).   
 
Many chemicals in CSC are cytotoxic.  Cytotoxicity is an important factor in 
understanding the mechanisms of action of different chemicals on cells and tissues.  
Cytotoxicity is thought to play an important role in a number of pathological processes 
including inflammation and carcinogenesis.  Cytotoxicity may also modulate the activity 
of other agents including free radicals, cytokines, and genotoxins (Bombick et al., 1998).  
In order to determine the effects of smoke condensate on HGF proliferation, the doses of 
CSC particulate matter ranged from 0-800 µg/ml.  These concentrations were similar to 
human exposure according the following calculation.  As previously reported (Gao et al., 
2005a; Hellermann et al., 2002) each cigarette yields 26.1 mg of CSC.  At a half pack to a 
full pack (10-20 cigarettes) smoked per day per person, the exposure of CSC amounts to 
261-522 mg.  Since the amount of saliva that one person secretes in one day is 
approximately 1-1.5 liter, the CSC exposure doses is 174-522 µg/ml.  When the HGFs 
were exposed to CSC doses above 800 µg/ml (1000 µg /ml, 2000 µg/ml, or 4000 µg/ml) 
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in preliminary experiments, almost no HGFs could be observed alive in the tissue culture 
plates (data not shown).  This was the rationale for using the range of 0-800 µg/ml of 
CSC in this study.  Furthermore, the WST-1 and LDH results in project one showed that 
CSC is cytotoxic to HGFs at concentrations equal to or greater than 400 µg/ml and 
affects the cell proliferation of HGFs at concentrations equal to or greater than 200 µg/ml. 
 
In project one, the treatment time of CSC exposure to the HGFs was 72 hours.  In the 
preliminary experiments, 24 or 48 hours was too short for the CSC to fully affect the 
HGFs (data not shown).  Possible reasons include not enough time for the altered 
transcription to be seen at the translation level and for the MMPs to be activated.  
Another possible reason is that active MMP-2 has low collagenolytic activity and so 
higher amounts are needed to generate enough collagen degradation to be observed.  Cell 
culture media is regularly changed every 3-4 days to provide the nutritions for HGFs.  At 
72 hours, the effects of CSC on collagen could be observed.  This was the rationale for 
using 72 hours as the treatment time.  In project one, since almost no HGFs were still 
alive when the concentration reached 800 µg/ml, there were no data for membrane 
extracts at CSC concentration of 800 µg/ml. 
 
In project two, 2.4 µg/ml nicotine and 100 µg/ml CSC were used to compare their effects 
on the collagen degrading ability of HGFs.  According to the project one, CSC (100 
µg/ml) did not affect the proliferation of HGFs and was not cytotoxic to HGFs, as well as 
in assays routinely performed in the laboratory with CSC or nicotine (data not shown).  
However, when the concentration of CSC increased to 200 µg/ml, it had a negative effect 
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on HGF proliferation (data not shown).  Therefore, 100 µg /ml of CSC was utilized in the 
study.  2.4 µg/ml nicotine was used in this study to examine the effects of nicotine on 
HGFs because 2.4 µg is the level found in 100 µg of CSC.  A previous study showed that 
when the concentration of nicotine was less than 250 µg/ml, it did not produce any 
cytotoxic effects on the HGFs (Zhou et al., 2007).  Thus, 2.4 µg/ml nicotine did not 
produce significant negative effects on the proliferation of HGFs.   
 
In project three, 50 µg /ml of CSC was utilized as an experimental concentration.  Based 
on a previous study, a concentration of CSC less than 200 µg/ml did not affect the 
proliferation of HGFs and had no toxic effects on the HGFs (Zhang et al., 2009).  100 µg 
/ml of CSC may have no negative effects on HGFs, but the combined effects of 100 
µg/ml CSC and 10% (v/v) P. gingivalis supernatants reduced the cell viability of the 
HGFs.  Since one cigarette can produced 26.1 mg CSC, 50 µg /ml of CSC is clearly very 
low compared to the uptake by any average smoker of several cigarettes per day (Nagaraj 
and Zacharias, 2007; Zhang et al., 2009).  Furthermore, the results also demonstrated that 
10% (v/v) P. gingivalis supernatants and 50 µg/ml CSC plus 10% (v/v) P. gingivalis 
supernatant did not affect the proliferation of HGFs and have no toxic effects on the 
HGFs.  This was the rationale for using 50 µg /ml of CSC plus 10% (v/v) P. gingivalis 
supernatants.   
 
The Negative Effects of CSC on the Proliferation of HGFs 
The health of periodontal tissues depends on the normal functions of periodontal cells.  
The attachment, migration, growth, and differentiation of periodontal cells are critical 
 87
steps in the repair and regeneration of periodontal tissues.  Human gingival fibroblasts 
(HGFs) are the main cellular component of periodontal connective tissues.  Therefore, the 
normal functions of HGFs are very important to periodontal health.  In periodontal 
disease development, HGF migration plays an important role in cell attachment to the 
extracellular matrix (Pitaru and Melcher, 1983).  The control HGFs displayed a normal 
long spindle-shape with a parallel arrangement.  However, the HGFs treated with CSC 
produced a disordered alignment and some of the HGFs detached.   
 
In project one, the effects of the CSC increased with increasing concentrations of CSC 
gradually despite some variations.  The negative effects of the CSC varied at low 
concentrations.  This may be due to fact that there are many different components in the 
CSC and that each component has individual effects.  Some of the components may 
promote the proliferation of the cells, whereas other components may inhibit the 
proliferation of the cells.  Therefore, the net result is a balance of all the components.  
The results of this study showed the total effects of these components on the proliferation 
of HGFs.  At high concentrations (≥200 µg/ml), cell proliferation decreased with CSC 
treatment.  Luppi et al. (Luppi et al., 2005) reported that low concentrations of CSC 
increased proliferation of a bronchial epithelial cell line, whereas high concentrations 
were inhibitory as a result of cytotoxicity.  In the current study, similar results were also 
observed.  The cytotoxicity, as measured by LDH, increased with the increasing of 
concentrations of CSC; although at low concentrations, the cytotoxicity varied greatly.  
When the concentrations of CSC were more than 200 µg/ml, the toxic effects increase 
was dependent on the concentrations of the CSC.  Alonso et al. (Alonso De La Pena et 
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al., 2007) reported that the LDH in whole saliva could be useful as a biochemical marker 
of periodontal status.  In that study, the values of salivary LDH activity from individuals 
with periodontal disease were significantly higher than those obtained in people with a 
healthy periodontium.   
 
CSC Increased Collagen Degrading Ability of HGFs 
Periodontal disease is a very common inflammatory disease.  During the development of 
periodontal disease, collagen degradation occurs.  Collagen is the major extracellular 
component of gingiva.  The collagen degradation assays demonstrated the ability of 
HGFs to degrade type I collagen.  At low concentrations of CSC (≤100 µg/ml), the 
collagen degrading ability of the HGFs gradually increased with the increases in the CSC.  
Overall, an increase in MMP activity was observed in CSC treated HGFs.  Although the 
family members involved differed from the current study, Nordskog et al. (Nordskog et 
al., 2005) showed that exposure of endothelial cells to CSC resulted in the upregulation 
of MMP-1, MMP-8, and MMP-9.  Furthermore, Zhou et al. (Zhou et al., 2007) reported 
that nicotine, an active agent in CSC, could increase collagen degradation.  Other studies 
have shown that nicotine can bind to the teeth root surfaces in smokers, and alter gingival 
and periodontal ligament fibroblast attachment and proliferation in vivo (Chang et al., 
2002a; Gamal and Bayomy, 2002; Giannopoulou et al., 1999; James et al., 1999).  Tipon 
and Dabbous (Tipton and Dabbous, 1995) also suggested that nicotine itself may 
augment the destruction of the gingival extracellular matrix (ECM) occurring during 
periodontal inflammation associated with smokeless tobacco use.  However, the 
treatment of cardiac fibroblasts with nicotine leads to a decrease in collagenase activity 
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(Tomek et al., 1994).  These different results may be due to the differences in the 
fibroblast type, the CSC concentrations, and the treatment periods, as well as the levels of 
MMP production.  In this study, there was a considerable increase in TIMP-1 in the 
conditioned media.  This may be due to an attempt to balance the increasing production 
of MMPs in the conditioned media. 
 
The collagen degradation was limited to the area underneath the cell colonies, which 
suggests that the increased collagen cleavage was cell membrane associated.  Active 
MMP-2, MMP-14 (membrane type-1 MMP), and TIMP-2 increased in the membrane 
extracts of CSC treated HGFs.  These findings can be explained by the MMP-2 activation 
model proposed by Strongin et al. (Strongin et al., 1995).  In this model, the TIMP-2 
molecule serves as a bridging molecule for the binding of latent MMP-2 to active MMP-
14 on the cell membrane and then another molecule of MMP-14 activates the latent 
MMP-2 by cleaving its propeptide domain.  Therefore, more TIMP-2 may be recruited to 
the cell membrane to enhance complex formation and MMP-2 activation. Decreased 
TIMP-2 in the conditioned media resulted from relocalization of TIMP-2 to the cell 
membrane, thus leading to increased activation of MMP-2.  However, it should be noted 
that higher concentrations of TIMP-2 can inhibit the membrane bound MMPs and block 
MMP-2 activation by inhibiting all the MMP-14.  Balance between these membrane bond 
MMPs and TIMP-2 is critical in determining whether MMP-2 activation or inhibition 
occurs, but ratios can be challenging to understand because it is difficult to determine 
which MMPs and forms (active/latent) should be included (Strongin et al., 1995).  MMP-
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14 increased at the mRNA level and at the protein level in the cell membrane extracts.  
This also supported the MMP-14, TIMP-2 and MMP-2 activation model.  
 
MMP-2 has weak collagenolytic activity (Hannas et al., 2007) and thus the increase of 
active MMP-2 could be responsible, in part, for increasing the collagen degradation 
mediated by HGFs.  In addition, MMP-14 can also degrade type I collagen at a slow rate 
(Strongin et al., 1995).  As mentioned previously, the level of MMP-2 increased in the 
conditioned medium from CSC treated HGFs.  MMP-2 has limited ability to cleave type I 
collagen and is not concentrated at a central location in the media as it is on the cell 
membrane, where it may affect type I collagen turnover because of a higher localized 
level of active MMP-2 (Strongin et al., 1995).  
 
The mechanisms by which CSC regulates the MMPs are currently unclear.  Previous 
research has focused mainly on nicotine.  Some studies have shown that nicotine can 
affect the production and distribution of gingival fibroblast cell surface proteins 
(Leonardi et al., 1999) and the activation of latent MMP-2 by MMP-14 at higher 
concentrations (Stanton et al., 1998).  In this study, the HGFs exposed to CSC had more 
rounded edges. This may imply that CSC can also affect the cytoskeleton and/or cell 
attachment receptors (Stanton et al., 1998; Tomasek et al., 1997).  Therefore, CSC might 
cause the redistribution of cell surface proteins such as the integrins and the membrane 
type-MMPs, which could subsequently affect the activation of latent MMP-2 (Zhou et al., 
2007).   
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Other Effects of CSC on Cells 
CSC affects the pro-inflammatory cytokines.  Chujo et al. (Chujo et al., 2010 ) showed 
that CSC induce pro-inflammatory cytokine expression from synovial cells and 
exacerbate collagen-induced arthritis in mice.  When human fibroblast-like synoviocytes 
were treated with CSC, the expression levels of interleukin (IL)-1alpha, IL-1beta, IL-6, 
IL-8, and CYP1A1 mRNAs were up-regulated in time- and dose-dependent manners 
(Shizu et al., 2008).  Mahanonda et al. (Mahanonda et al., 2009) showed that cigarette 
smoke extract stimulated IL-8 expression from human gingival epithelial cells.  Nicotine 
(162 µg/ml) showed similar effects but to a much lesser extent, thus implying that non-
nicotine components in cigarette smoke extract may be primarily responsible for these 
immune-modulating effects (Mahanonda et al., 2009).  Almasri et al. (Almasri et al., 
2007) showed that nicotine significantly increased the expression levels of growth 
regulated oncogene (GRO)-alpha, IL-7, IL-10, and IL-15.  Wendell et al. (Wendell and 
Stein, 2001) also showed that nicotine can stimulate human gingival fibroblast expression 
of IL-6 and IL-8.  Johnson et al. (Johnson et al., 2010) showed that 162 µg/ml nicotine 
up-regulated the production of IL-1 alpha, but had no significant effect on IL-8 
production in gingival keratinocytes.  Cytokines can affect the expression of the MMPs 
(Mauviel, 1993; Ries and Petrides, 1995; Rooprai et al., 2000) and MMPs can lead to 
increased collagen degradation as seen in periodontal disease. 
 
Role of Nicotine in Collagen Degradation of HGFs 
In project two, the level of nicotine (2.4 µg/ml) in CSC did not play a major role in 
altering the collagen degradation mediated by the HGFs, and it had little influence on the 
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protein and mRNA levels of MMP-2, MMP-14, and TIMP-2.  Zhou et al. (Zhou et al., 
2007) reported that nicotine at 250 µg/ml did increase HGF-mediated collagen 
degradation.  Some studies have shown that nicotine can bind to teeth root surfaces and 
built up in smokers, and alter gingival and periodontal ligament fibroblast attachment and 
proliferation in vivo at concentrations of 250-10000 µg/ml (Chang et al., 2002a; Gamal 
and Bayomy, 2002; Giannopoulou et al., 1999; James et al., 1999).  Tipon and Dabbous 
(Tipton and Dabbous, 1995) suggested that nicotine (≥ 250 µg/ml) may augment the 
destruction of the gingival extracellular matrix occurring during periodontal 
inflammation.  The saliva samples from smokeless tobacco users contained as much as 
1560 µg/ml of nicotine (Hoffmann and Adams, 1981) and smoking one cigarette can 
expose the oral cavity to 1000 µg of nicotine (Benowitz and Jacob, 1984) without being 
toxic to the user.  According to a recent study from Robson et al. (Robson et al., 2010), 
the concentrations of nicotine in the smoker’s saliva ranged from about 0.9 µg/ml to 4.6 
µg/ml depending on the amount of tobacco use.  Another recent report from Malhotra et 
al. (Malhotra et al., 2010) showed that the concentrations of nicotine in gingival 
crevicular fluid ranged up to 6 µg/ml.  The concentration of nicotine (2.4 µg/ml) used in 
this study was within these ranges.   
 
Combined Effects of CSC and P. gingivalis on the Collagen Degrading Ability of 
HGFs 
Project three demonstrated that CSC can increase the P. gingivalis enhanced collagen 
degradation by HGFs.  During this process, the balance of the MMPs and TIMPs may 
play a key role.  In this study, active MMP-1 (47 kDa), active MMP-2 (67 kDa), and 
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active MMP-3 (44 kDa) increased in the 50 µg/ml of CSC plus 10% (v/v) P. gingivalis 
supernatant treated group when compared to the other groups.  Active collagenase-1 
(MMP-1) is capable of cleaving native fibrillar collagen type I at specific sites between 
Gly775-Ile776 of the 1 chains and Gly775-Leu776 residues of the 2 chain.  Active 
gelatinase-A (MMP-2) also has weak catalytic activity towards the fibrillar collagens 
(Ala-aho and Kahari, 2005).  MMP-14 (membrane type 1 MMP, MT1-MMP) also can 
cleave type I collagen (Aznavoorian et al., 2001).  This suggests that several MMPs may 
be players in the increased collagen degradation seen in this study.  At 5 days, the 
collagen coated in the wells was totally degraded by the HGFs treated with 50 µg/ml of 
CSC plus 10% (v/v) P. gingivalis.  However, this degradation was inhibited by the MMP 
inhibitor MG6001.  Furthermore, in zymography, the gelatin degradation was inhibited 
by another MMP inhibitor 1, 10-phenothroline.  All these results demonstrated that the 
MMPs play a role in degrading the type I collagen.  The levels of TIMP-1 and TIMP-2 in 
the conditioned media decreased in spite of the increase in the mRNA level.  This may be 
because P. gingivalis supernatant can degrade the TIMP-1 and TIMP-2 proteins (Andrian 
et al., 2007; Grenier and Mayrand, 2001; Sato et al., 2009).  In addition, the TIMP-2 level 
decreased in the conditioned media and increased in the membrane extracts probably due 
to relocalization.  The balance between the MMPs and TIMPs were disturbed, which lead 
to increased collagen degradation.  
 
The mechanisms of how CSC increased the effects of the P. gingivalis enhanced collagen 
degradation are not very clear.  One of the possible mechanisms is that the increased 
mRNA levels of the MMPs in the 50 µg/ml of CSC plus 10% (v/v) P. gingivalis 
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treatment groups were higher than the increased mRNA levels of the TIMPs.  In this 
study, the mRNA level of MMP-1, MMP-2, and MMP-14 increased in the 50 µg/ml of 
CSC plus 10% (v/v) P. gingivalis supernatant treated HGFs when compared to the other 
treatment groups and the control, which is consistent to the results at the protein levels.  
These results were consistent with previous studies.  Exposure of endothelial cells to CSC 
resulted in the up-regulation of MMP-1, MMP-8, and MMP-9 mRNA levels (Nordskog 
et al., 2005) and P. gingivalis supernatant led to the up-regulation of MMP-1 and MMP-2 
mRNA levels in HGFs (Zhou and Windsor, 2006).  
 
Another possible mechanism may be interpreted by the MMP-1 activation model (Ala-
aho and Kahari, 2005; Schuppan and Hahn, 2000).  MMP-1 is secreted as 52 kDa and 57 
kDa latent forms.  MMP-3 can superactivate the proMMP-1 and convert them into the 42 
and 47 kDa active forms (Ala-aho and Kahari, 2005; Beklen et al., 2007; DeCarlo et al., 
1997).  In this study, the increase of active MMP-3 (44 kDa) accompanied the increase of 
active MMP-1 (47/42 kDa), especially in 50 µg/ml of CSC plus 10% (v/v) P. gingivalis 
supernatant treated HGFs.   
 
Furthermore, MMP-14 can activate proMMP-2 by forming a trimolecular complex of 
MMP-14/TIMP-2/proMMP-2 (Hotary et al., 2003) and then another molecule of MMP-
14 mediates the cleavage of the propeptide domain of MMP-2. Upon the activation of 
MMP-2, the amino-terminus of MMP-14 is, in turn, cleaved off, which results in a 
smaller fragment of MMP-14 (Strongin et al., 1995).  In the current study, the proMMP-
2, MMP-2, MMP-14 and TIMP-2 in the cell membrane extracts supported the above 
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activation model.  Furthermore, the existence of a low-molecular weight MMP-14 
fragment (44 kDa) in the cell membrane extracts also supported this model.  Overall, an 
increase in the MMPs was observed.  MMPs can also act as initiators of other proMMP 
activation cascades (Ala-aho and Kahari, 2005).  However, these are just some of 




Summary and Conclusion 
 
This chapter provides a general summary and conclusions from the three projects that 
were described in the previous chapters of this dissertation. This chapter also discusses 
the significance of these studies in general terms and suggests future directions for 
continuing the research. 
 
The broad objective of these investigations was to increase the understanding of the 
causal association between periodontal disease and tobacco.  The rationale for our 
research studies was to define the etiological roles of smoking on harmful health effects, 
especially periodontal disease. 
 
These studies collectively were aimed at exploring the molecular and biological 
mechanisms underlying the possible etiological links between tobacco and periodontal 
disease.  In general, it was hypothesized that tobacco can increase human gingival 
fibroblast mediated-collagen degradation as seen in periodontal disease, and that the 
combination of cigarette smoke condensate (CSC) and P. gingivalis supernatant can 
further increase the collagen degrading ability of HGFs.  The possible causal 
relationships between induced tissue destruction (i.e., periodontal disease) and tobacco in 
three in vitro investigations were explored.  These in vitro studies lay the ground work for 
future animal studies.  
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The findings from the first project showed that HGF cell proliferation decreased and 
cytotoxicity of CSC increased when the concentrations of CSC increased.  Cell 
proliferation decreased more than 50% when concentrations of CSC were above 200 
µg/ml and cytotoxicity of CSC increased more than 30% when the concentrations of CSC 
were above 400 µg/ml.  CSC increased HGF collagen degrading ability, especially at the 
concentration of 100 µg/ml when compared to the control.  CSC increased the production 
of proMMP-1, proMMP-2, MMP-14, and TIMP-1, as well as decreased the production of 
TIMP-2, in the conditioned media.  Furthermore compared to the control group, CSC 
increased MMP-2, MMP-14, and TIMP-2 in the membrane extracts, especially at 
concentrations of 50-100 µg/ml.  However, this study did not identify which components 
in the CSC play key roles in these processes since CSC is a mixture.  In brief, CSC 
affects HGF proliferation and is toxic at CSC concentrations of 400 µg/ml and above.  
CSC can increase the collagen-degrading ability of HGFs by altering the production and 
localization of the MMPs and TIMPs.  
 
The results of the second project confirmed the results of first study in that 100 µg/ml 
CSC increased the collagen degradation by HGFs and enhanced the levels of TIMP-2, 
MMP-14 and active-MMP-2 in the membrane extracts of HGFs, as well as their mRNA 
levels.  CSC also increased the level of active MMP-2 in the conditioned media.  
However, 2.4 µg/ml nicotine, one of the major components and the most 
pharmacologically active agent in tobacco (2.4% nicotine in the CSC), had little influence 
on collagen degradation, as well as on the protein and mRNA levels of MMP-2, MMP-
14, and TIMP-2 from the HGFs.  Therefore, further studies examining other components 
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of CSC need to be taken.  In brief, CSC may increase HGF-mediated collagen 
degradation by affecting membrane associated MMP-2, MMP-14, and TIMP-2, and the 
level of nicotine in the CSC may only play a limited role in this process. 
 
The third project included a bacteria factor (P. gingivalis supernatant).  P. gingivalis is 
one of the most abundant oral microorganisms associated with periodontal disease.  The 
study illustrated that the combination of CSC and P. gingivalis supernatant increased 
collagen degradation, the protein levels of the active forms of MMP-1, MMP-2, MMP-3, 
and MMP-14 in the conditioned media, and the low molecular weight fragment of MMP-
14 in the membrane extracts, as well as the mRNA levels of MMP-1, MMP-2, and MMP-
14.  In brief, the combined effects of CSC and P. gingivalis increased collagen 
degradation by HGFs by destroying the balance between the MMPs and TIMPs at 
multiple levels. 
 
The cumulative evidence from these three studies supports the existence of biological 
mechanisms that could plausibly explain an etiological relationship between tobacco and 
tissue destruction (e.g., periodontal disease) and contribute to the risk of periodontal 
disease in susceptible individuals.  These biological mechanisms mediating such a 
relationship are still not fully understood. However, scientists are successfully putting 
together the pieces of this puzzle. Future animal studies, as well as large and well 
controlled clinical trials, are necessary to develop the strategies to prevent and treat 
tobacco-related periodontal disease. 
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Significance of the Results 
The results of the current studies provide data concerning the effects that CSC has on 
HGF-mediated collagen degradation in regards to affecting the expression of the 
MMPs/TIMPs, and may provide insights into the prevention and treatment options for 
tobacco-related periodontal disease that could be developed in the future. 
 
Periodontal disease continues to be the leading cause of tooth loss in the U.S. and 
worldwide, and its impact on global health is immense.  Traditional methods do not 
completely prevent and treat periodontal disease, and there is an increasing interest in 
studying the mechanisms of periodontal tissue destruction.  The results of these studies 
can be considered as a step forward in determining how tobacco leads to periodontal 
tissue destruction.  Thus, these results could be significant in providing new strategies for 
the prevention of periodontal disease through rebuilding the balance between the MMPs 
and TIMPs.  
 
Future Directions 
The studies described in this dissertation can be considered as preliminary investigations 
that possess great potential to develop more focused investigations.  The fundamental 
objective of these studies was to assess the role of tobacco in cell-mediated collagen 




The first research project assessed CSC’s cytotoxicity and its effects on cell proliferation, 
which provided suitable working concentrations of CSC for studies with the HGFs.  
Although collagen degradation might be the most important pathologic activity assay in 
the context of these studies, multiple assays examining additional aspects of the HGFs 
should be undertaken.  Additional assays including those monitoring other proteases and 
cytokines should be employed in future studies. 
 
The second project compared the effects of CSC and nicotine at the level in CSC on the 
collagen-degrading ability of HGFs.  The results of this study showed that the level of 
nicotine in CSC may only play a limited role in this process.  CSC is a complex mixture 
of components (Choi et al., 2008; Talhout et al., 2007) (e.g., benzo[α] pyrene, 
hydroquinone, acetaldehyde, acrolein, 2-naphthylamine, etc.) besides nicotine, which 
may be involved in the process of enhancing HGF-mediated collagen degradation and 
lead to periodontal disease.  If the component or components responsible for the 
increased collagen degradation could be identified, the component or components could 
possibly be removed from the tobacco or interventions could be developed to block the 
ability of this component or components to enhance HGF-mediated collagen degradation 
in hopes to prevent tobacco related periodontal disease.  Future studies on the other 
components in CSC should be undertaken. 
 
In the third project, P. gingivalis supernatant was utilized to study the combined effects 
with CSC on human gingival fibroblasts.  Future studies, similar to these, could be 
conducted utilizing other bacteria (e.g., Actinobacillus actinomycetemcomitans) with 
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cigarette smoke condensate in order to better understand bacterial and tobacco 
interactions with human gingival fibroblasts.   
 
Each study in the dissertation investigated the effects of tobacco on HGFs, which came 
from one non-smoker patient. Individuals with the similar periodontal pathogens may 
experience different disease processes and/or severity (Newman, 1997; Phipps et al., 
1997).  Susceptibilities to periodontal disease have been demonstrated to be associated 
with certain genotypic and phenotypic characteristics (Lekic et al., 1997).  For example, 
data from twin studies indicated that about half the population variance in periodontitis 
can be attributed to genetic factors (Corey et al., 1993; Michalowicz et al., 1991a; 
Michalowicz et al., 1991b; Michalowicz et al., 2000).  Moreover, accumulating evidence 
shows that genetic variations in or near cytokine genes can affect the systemic 
inflammatory responses in people with periodontitis (D'Aiuto et al., 2004; Kornman et 
al., 1997).  Heterogeneity exists in HGFs in regard to their collagenolytic activity in the 
presence of P. gingivalis (Zhou and Windsor, 2007).  Heterogeneity of host 
immunological risk factors exist in patients with aggressive periodontitis (Takahashi et 
al., 2001).  Furthermore, in the presence of P. gingivalis, collagen was more readily 
cleaved by gingival fibroblasts from inflamed tissues than from healthy tissues (Al-
Shibani and Windsor, 2008).  Biological diversity may also affect the HGF collagen 
degrading ability under the influence of environmental factors including tobacco use.  For 
example, clinical evidence shows that some smokers even with very high dental plaque 
index still have good periodontal status and do not develop periodontal disease 
(Kondratiev et al., 2008). However, there is no data about the heterogeneity of the effects 
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of CSC on human gingival fibroblasts.  Therefore, future studies should be conducted to 
assess the heterogeneity of different HGF cell lines in determining their CSC stimulated 
collagen-degrading ability. 
 
As described earlier in this dissertation, traditional reverse transcript PCR techniques was 
used to detected the mRNA change of MMPs and TIMPs of tobacco treated HGFs.  
However, RT-PCR possesses some limitations including low sensitivity and no real-time 
detection.  Further studies can be conducted using real-time PCR or other molecular 
techniques to detect the changes on mRNA levels. 
 
Since all these studies were in vitro, future studies should use animal models to 
investigate the role of tobacco (with or without bacteria) in periodontal disease and its 
mechanisms.  Furthermore, these studies just exposed the HGFs to CSC for a short period 
of time and focused on assessing the changes within this short time frame.  Actually, 
patients are exposed to tobacco for a very long period of time. Future studies can explore 
the long-term effects such as on inflammatory cytokines.  These studies should be more 
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cell carcinoma and odontogenic ghost cell tumor. Geng Ning, Ban Yu, Chen Yu, Bao 
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Shenyang, China, 2006.  
 
 □ HONORS AND AWARDS 
 Trident Award for Innovation in Oral Care Research, Indiana Section American 
Association for Dental Research /Indiana University School of Dentistry Research 
Day, Indianapolis, IN, 2009  
 Educational Enhancement Grant, Graduate School, Indiana University 
Indianapolis, IN, 2008  
 Travel Fellowship Award, Graduate School, Indiana University Indianapolis, IN, 
2008  
 Research Investment Fund (RIF) Fellowship for Ph.D. studies, IUSD, 
Indianapolis, Indiana (2006-2011) 
 Kwang-Hua Fellowship (first prize) School of Graduate, Sichuan University 
(2004, 2005) 
 Colgate Medicine Prize School of Stomatology, Tianjin Medicine University 
(2000, 2002) 




1. Certificate of Dentistry license, China (active currently)                       2003  
2. Certificate for CPR & AED, U.S.A.                                                       2009 
 □ TEACHING EXPERIENCES 
 Teaching Assistant for Blood Pressure Competency Examination for Systems 
Approach to Biomedical Sciences (SABS) I course, Indiana University School of 
Dentistry, spring semester, 2009 
 Teaching Assistant for Hematology lab in SABSII course, Indiana University 
School of Dentistry, spring semester, 2009 
 Teaching Assistant for Enzyme-linked Immunosorbent Assay (ELISA) to 
determine the Level of Salivary IgA antibodies to streptococcus Mutans for 
SABSI course, Indiana University School of Dentistry, spring semester, 2008 and 
2009 
 Teaching Assistant for musculoskeletal module for SABSI course, Indiana 
University School of Dentistry, spring semester, 2009 
 Bench Instructor for Oral Pathology course in West China College of 
Stomatology, Sichuan University, China, fall semester, 2004 and 2005  
 
□ SERVICE ACTIVITIES 
 Indiana University School of Dentistry Graduate Student Council (GSC),   
2007-2008 
 Indiana University School of Dentistry Graduate Student Professional Conduct 
Committee (GSPCC), 2009-2011 
